Azelastine NDC 67877-477

NDC codes

FDA NDC Directory

Product NDC (as listed)67877-477Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67877-0477Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67877-477-50	67877047750	1 SPRAY, METERED in 1 BOTTLE (67877-477-50)Marketed from Aug 18, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Azelastine
Generic name (nonproprietary): azelastine
Active ingredients: Azelastine hydrochloride — 137 ug/1
Dosage form: Spray, Metered
Route: Nasal
Labeler: Ascend Laboratories, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208156
Marketing start: Aug 18, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Histamine H1 Receptor Antagonists (Mechanism)
Identifiers: Product ID 67877-477_b5281403-77e2-44a3-966f-d9c9efb86453SPL ID b5281403-77e2-44a3-966f-d9c9efb86453SPL set ID 77b20c6b-f30f-42a9-a0ef-d5d0bd3feb56RxCUI 1797867UNII 0L591QR10IUPC 0367877477503
Pharmacologic class: Histamine-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Nasal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467877047750 followed by a unit qualifier and the quantity

Package 67877-0477-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 26, 2026.

Indications (excerpt from the label)

Azelastine HCl Nasal Spray is indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older, and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older. Azelastine HCl Nasal Spray is an H 1 -receptor antagonist indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)